510(k) Report

510(k) · Cleared

Cleared

DELTA4

K052920510(k) TraditionalCleared Jan 12, 200687-day reviewClass II21 CFR 892.5050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Scandidos AB · IYE Accelerator, Linear, Medical

Cleared on Jan 12, 2006 as substantially equivalent to K031634 (Wellhofer Dosimetrie, 2003) after an 87-day review. Its family tree reaches back 2 generations to 1994. 1 later device descends from it.

Decided
Jan 12, 2006
Review
87 days
Class
Class II
Product code
IYE
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K935928 (1994). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2015: 1 descendant clearedK935928 · Rit 113 Film Analysis System · Radiological Imaging Technology, Inc. · 1994K031634 · Omnipro I'mrt · Wellhofer Dosimetrie · 20031990200020102020
Descendants, by generation 1 generation forward: 1 descendant K031634 · Omnipro I'mrt · Wellhofer Dosimetrie · 2003K935928 · Rit 113 Film Analysis System · Radiological Imaging Technology, Inc. · 19940
  1. Root · 2 generations backK935928 Rit 113 Film Analysis SystemRadiological Imaging Technology, Inc. · 1994
  2. 1 generation backK031634 Omnipro I'mrtWellhofer Dosimetrie · 2003
  3. This deviceK052920 DELTA4Scandidos AB · 2006
  4. Descendant · cites it directly · 0 of its ownK151180 ScandiDos Delta4 Phantom+Scandidos AB · 2015

Most influential descendants

Showing 1 of 1 · See all
  • K151180ScandiDos Delta4 Phantom+Scandidos AB · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K935928Rit 113 Film Analysis SystemRadiological Imaging Technology, Inc.1994—
−1K031634Omnipro I'mrtWellhofer Dosimetrie2003—
0 (this device)K052920DELTA4Scandidos AB2006—
+1K151180ScandiDos Delta4 Phantom+Scandidos AB2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
FIG. 1 — Lineage of K052920, 1994–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IYE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IYE device

  1. #1 K252977 Halcyon, Ethos Radiotherapy System (5.0)score 18.8 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K031634Omnipro I'mrt
Summary page 1
…D001 04 003 02 9_2 (9_6) 3 PREDICATE DEVICES OmniPro I'mRT 510(k) number K031634 Trade name OmniPro I'mRT Intended Use The intended use of the OmniPro I'mRT system is to: *…
Wellhofer Dosimetrie2003—
*—MapCheck
Named without a submission number
—
*—CIRS Model 008 Dynamic Thorax Phantom
Named without a submission number
—

Also cleared against K031634: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K151180ScandiDos Delta4 Phantom+Scandidos AB20150

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 9.1 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K151180 (Scandidos AB, 2015) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K031634.

How does its category compare?

All IYE devices

IYE Accelerator, Linear, Medical: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · IYE

12in 2025

2007: 232008: 142009: 202010: 232011: 112012: 282013: 182014: 202015: 202016: 212017: 232018: 212019: 192020: 202021: 192022: 122023: 182024: 92025: 122026 (partial year): 14
2007high 28 (2012) · low 9 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IYE

170in 2025

2007: 44 days median2008: 69 days median2009: 63 days median2010: 74 days median2011: 94 days median2012: 106 days median2013: 88 days median2014: 100 days median2015: 108 days median2016: 97 days median2017: 94 days median2018: 58 days median2019: 83 days median2020: 67 days median2021: 86 days median2022: 172 days median2023: 129 days median2024: 239 days median2025: 170 days median2026 (partial year): 120 days median
2007high 239 (2024) · low 44 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IYE

1in 2025

2007: 782008: 492009: 222010: 272011: 732012: 202013: 112014: 142015: 82016: 72017: 72018: 72019: 22020: 42021: 52022: 32023: 72024: 12025: 12026 (partial year): 4
2007high 78 (2007) · low 1 (2024)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IYE

101in 2025

2007: 1552008: 1142009: 1742010: 2462011: 2802012: 1282013: 962014: 1242015: 1002016: 972017: 1252018: 852019: 912020: 742021: 682022: 662023: 1282024: 812025: 101
2007high 280 (2011) · low 66 (2022)2025

MAUDE reports naming product code IYE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007234478155
2008146949114
2009206322174
2010237427246
2011119473280
20122810620128
201318881196
20142010014124
2015201088100
20162197797
201723947125
20182158785
20191983291
20202067474
20211986568
202212172366
2023181297128
20249239181
2025121701101
2026141204—

What is it indicated for?

The intended use of Delta4 is quality assurance of patient specific treatment delivery prior to the treatment in IMRT and 4DRT (respiratory gating and tumor tracking).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K052920: DELTA4.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K052920

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026